| | |
| 0314 |
10:45 AM | Utility of Calgary Biofilm Device (CBD) for Candida Biofilm Studies Y.H. SAMARANAYAKE, N. PARAHITIYAWA, L.P. SAMARANAYAKE, J.Y.Y. YAU, B.P.K. CHEUNG, and J. YE, University of Hong Kong, Hong Kong |
| 0315 |
11:00 AM | Cobalt, nickel, or zinc ion effects on histatin antifungal activity F. SHELTON1, M.M. JEFFERSON2, and E.L. THOMAS2, 1University of Tennessee, College of Dentistry, Memphis, USA, 2University of Tennessee, Memphis, USA |
| 0316 |
11:15 AM | Oral yeast profile in nasopharyngeal carcinoma patients following adjuvant chemotherapy E.H.N. POW1, W.K. LEUNG2, A.S. MCMILLAN1, and D.L.W. KWONG1, 1University of Hong Kong, Hong Kong, 2University of Hong Kong, Hong Kong SAR, China |
| 0317 |
11:30 AM | Candida glabrata Biofilms: Evaluation on Polystyrene and Polymethyl Methacrylate Models A.K. BURN1, S.W. REDDING1, J. LOPEZ-RIBOT2, W. KIRKPATRICK2, B. BHATT1, and T. PATTERSON1, 1University of Texas - San Antonio / Health Science Ctr, USA, 2University of Texas - San Antonio / Health Science Ctr |
| 0318 |
11:45 AM | In Vitro Modelling of Oral Candidiasis M.H. THORNHILL, University of Texas Health Science Center, San Antonio, USA, A. CRUCHLEY, Barts & the London, United Kingdom, J. LOPEZ-RIBOT, University of Texas - San Antonio / Health Science Ctr, and R.P. ALLAKER, St. Bartholomews & the Royal London, United Kingdom |
| 0319 |
12:00 PM | Candida glabrata is resistant to the antifungal protein histatin 5 E.J. HELMERHORST, A. BERI, R.F. TROXLER, and F.G. OPPENHEIM, Boston University, MA, USA |
| 0320 |
12:15 PM | Cellular Characteristics Rendering Candida glabrata Resistant to Histatin 5 E.J. HELMERHORST1, C. VENULEO2, M.K. HOSTETTER3, R.F. TROXLER4, and F.G. OPPENHEIM1, 1Boston University, Goldman School of Dental Medicine, MA, USA, 2Boston University, School of Dental Medicine, MA, USA, 3Yale-New Haven Children's Hospital, Yale University, CT, USA, 4Boston University, School of Medicine, MA, USA |
|